AGREEMENT

    


    This
      AGREEMENT,
      dated
      as of July 28,
      2006
      (the
      “Agreement”),
      by
      and among TXP Corporation, a Nevada corporation (the “Company”) and James Von
      Ehr II (collectively, the “Investor”).

     

    BACKGROUND

     

    WHEREAS,
      the
      Investor desires to pledge an aggregate of $2,000,000 in free-trading shares
      of
      common stock of Adobe Systems Incorporated (NASDAQ:ADBE), Fossil Incorporated
      (NASDAQ:FOSL) or such other shares of free-trading common stock having a value
      of $2,000,000 in the aggregate as may be agreed upon after the date hereof
      between the parties hereto (the “Collateral”),
      on
      behalf of the Company in favor of First Bank of Canyon Creek, or such other
      lending or financing institution as may be agreed upon after the date hereof
      between the parties hereto (a “Lender”),
      as
      Collateral for a loan to the Company from a Lender in an amount up to $2,000,000
      (the “Loan”),
      which
      will be further guaranteed personally and through the pledge of Common Stock
      (as
      defined below) beneficially owned by Michael Shores, the Company’s Chief
      Executive Officer.

    


    WHEREAS,
      the
      Company wishes to issue to the Investor warrants (the “Warrants”),
      in
      the form annexed hereto as Exhibit
      “A”,
      to
      purchase 320,000 shares (the “Warrant
      Shares”)
      of the
      Company’s common stock, par value $.001 per share (the “Common Stock),
      exercisable into shares of the Company’s Common Stock at a price equal to $0.50,
      subject to adjustment as set forth in the Warrants, as consideration and in
      exchange for the Investor agreeing to: (i) pledge the Collateral on behalf
      of
      the Company for the Loan, and (ii) execute such additional documentation as
      may
      be required to effectuate the pledge of the Collateral to a Lender
      (collectively, the “Transaction
      Documents”).

    


    WHEREAS,
      the
      issuance of the Warrants will be made in reliance upon the provisions of Section
      4(2) ("Section
      4(2)")
      and/or
      Section 4(6) of the United States Securities Act of 1933, as amended, and/or
      Regulation D ("Regulation
      D")
      and
      the other rules and regulations promulgated thereunder (the "Securities
      Act"),
      and/or upon such other exemption from the registration requirements of the
      Securities Act as may be available with respect to any or all of the investments
      in securities to be made hereunder.

    


    All
      capitalized terms not otherwise defined herein shall have the meanings given
      to
      them in the Transaction Documents.

     

    NOW
      THEREFORE in
      consideration of the premises and the mutual covenants, agreements,
      representations and warranties contained herein, and other good and valuable
      consideration, the receipt and sufficiency of which is hereby acknowledged,
      the
      parties hereto hereby agree as follows:

    


    
      
         

      

      
         

        
          

        

      

      
         

      

    

    ARTICLE
      1.

    THE
      AGREEMENTS

     

    


    1.1
      Agreements.
      Subject
      to the terms and conditions set forth in this Agreement, the Warrants, and
      Transaction Documents, the Company and the Investor hereby agree to execute
      this
      Agreement containing the following provisions which shall be effective as of
      the
      date hereof: 

    


    1.2
      Consideration.
      In
      consideration of the Investors agreement to pledge the Collateral to a Lender,
      the Company agrees to:

    


    (a) issue
      to
      the Investor the Warrants; and

    


    (b) pay
      to
      the Investor a one-time commitment fee during the Term (as defined in Section
      1.4(a) of this Agreement) equal to $40,000 (the “Commitment
      Fee”),
      no
      later than 90 days after the Collateral is deposited into the account of a
      Lender; provided, however, that the Company shall pay an additional Commitment
      Fee within 90 days after the renewal of the Loan by a Lender. The commitment
      fee
      will be fully-earned as of the date of each such deposit and not subject to
      any
      refund as a result of the subsequent termination of the Loan or otherwise.
      

    


    1.3
      Registration
      Rights.
      (a)
Mandatory
      Registration.
      The
      Company shall prepare, and, as soon as practicable, but in no event later than
      forty
      five (45) days after the date hereof (the
      “Scheduled
      Filing Date”),
      file
      with the SEC a separate Registration Statement on Form SB-2 covering the resale
      of all of the Warrant Shares. In the event that Form SB-2 is unavailable for
      such registration, the Company shall use such other form as is available for
      such registration. The Registration Statement prepared pursuant hereto shall
      register for resale that number of shares of Common Stock equal to the number
      of
      Warrant Shares as of the Scheduled Filing Date. The Company shall use its best
      efforts to have the Registration Statement declared effective by the SEC as
      soon
      as practicable, but in no event later than one hundred twenty (120) days after
      the Scheduled Filing Date (the
      “Scheduled
      Effective Date”).
      

    


    (b) Piggy-Back
      Registrations.
      If, at
      any time prior to the expiration of the Registration Period (as hereinafter
      defined) that there
      is
      not an effective Registration Statement covering all of the Warrant
      Shares,
      the
      Company proposes to file with the SEC a Registration Statement for its own
      account or the account of others under the 1933 Act of any of its securities
      (other than a Registration Statement on Form S-4 or Form S-8 (or their
      equivalents at such time) relating to securities to be issued solely in
      connection with any acquisition of any entity or business or equity securities
      issuable in connection with stock option or other employee benefit plans),
      the
      Company shall promptly send to the Investor written notice of the Company's
      intention to file a Registration Statement and of the Investor's rights under
      this Section 1.3(b) and, if within five (5) days after receipt of such notice,
      the Investor shall so request in writing, the Company shall include in such
      Registration Statement all or any part of the Warrant shares the Investor
      requests to be registered for resale, subject to the priorities set forth in
      this Section 1.3 (b). No right to registration of Warrant Shares under this
      Section 1.3(b) shall be construed to limit any registration required under
      Section 1.3(a). The obligations of the Company under this Section 1.3(b) may
      be
      waived by the Investor. In the event that the Registration Statement being
      filed
      by the Company under this Section 1.3(b) is for an underwritten offering, the
      Investor shall, unless otherwise agreed to by the Company, offer and sell the
      Warrant Shares in an underwritten offering using the same underwriter or
      underwriters and, subject to the provisions of this Agreement, on the same
      terms
      and conditions as other shares of Common Stock included in such underwritten
      offering. If the managing underwriter(s) advise the Company, in writing, that
      in
      their reasonable good faith opinion, marketing or other factors dictate that
      a
      limitation on the number of shares of Common Stock which may be included in
      the
      Registration Statement is necessary to facilitate and not adversely affect
      the
      proposed offering, then the Company shall include in such registration:


     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    
 

    (1)       first,
      all securities the Company proposes to sell for its own account;

    


    (2)  second,
      all of the securities the Investor requests to be registered for his account;
      and

    


    (3)  third,
      up
      to the full number of securities proposed to be registered for the account
      of
      the holders of securities entitled to inclusion of their securities in the
      Registration Statement by reason of demand or mandatory registration
      rights.

    


    (c)
       The
      Company shall keep each of the Registration Statement required to be filed
      hereunder effective pursuant to Rule 415 at all times until (i) the date as
      of
      which the Investor may sell all of the Warrant Shares covered by such
      Registration Statement pursuant to Rule 144(k) promulgated under the 1933 Act
      (or successor thereto) or (ii) the date on which (A) the Investor shall have
      sold all of the Warrant Shares covered by such Registration Statement and (B)
      none of the Warrants are outstanding (the "Registration
      Period"),
      each
      of which Registration Statements (including any amendments or supplements
      thereto and prospectuses contained therein) shall not contain any untrue
      statement of a material fact or omit to state a material fact required to be
      stated therein, or necessary to make the statements therein, in light of the
      circumstances in which they were made, not misleading. 

    


    (d) The
      Company shall prepare and file with the SEC such amendments (including
      post-effective amendments) and supplements to a Registration Statement and
      the
      prospectus used in connection with such Registration Statement, which prospectus
      is to be filed pursuant to Rule 424 promulgated under the 1933 Act, as may
      be
      necessary to keep such Registration Statement effective at all times during
      the
      Registration Period, and, during such period, comply with the provisions of
      the
      1933 Act with respect to the disposition of all Warrant Shares covered by such
      Registration Statement until such time as all of such Warrant Shares shall
      have
      been disposed of in accordance with the intended methods of disposition by
      the
      Investor as set forth in such Registration Statement. 

    


    (e)
       The
      Investor agrees that the Company shall not be precluded from registering any
      additional shares of its Common Stock underlying the securities of the Company
      in the Registration Statement.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    
 

    (f) All
      expenses incurred in connection with
      registrations, filings, or qualifications pursuant to Section 1.3,
      including all registration, filing, and qualification fees; printers’ and
      accounting fees; fees and disbursements of counsel for the Company
      shall be
      borne and paid by the Company. (h) From
      and
      after the date of this Agreement, the Company shall not, without the prior
      written consent of Investor, enter into any agreement with any holder or
      prospective holder of any securities of the Company that would allow such holder
      or prospective holder to include such securities in any registration unless,
      under the terms of such agreement, such holder or prospective holder may include
      such securities in any such registration only to the extent that the inclusion
      of such securities will not reduce the number of the Warrant Shares of the
      Investor that are included.

    


    1.4          
      The
      Loan.

    


    (a) Term
      of the Loan. The
      Company agrees that the term of the Loan shall not exceed 24 months (the
“Term”).

    


    (b) Investor
      Approval.
       The
      Company agrees that it shall not procure any Loan with a Lender, or execute
      any
      definitive documentation in connection with a proposed Loan, without the prior
      written consent of the Investor, which shall not be unreasonably withheld;
      provided,
      however,
      that
      any request by a Lender of Investor to provide additional credit support or
      enhancement for any such Loan shall be grounds for Investor withholding consent
      to any such Loan. The Company shall provide written notice to the Investor
      which
      sets forth the terms of a proposed Loan at least 5 business days prior to the
      execution of definitive documentation in connection with such proposed
      Loan.
      The
      Investor shall have 3
      business
      days following receipt of the notice to reasonably object to the terms proposed
      Loan. In the event such terms and conditions are modified during the notice
      period, the Investors shall be given prompt notice of such modification and
      shall have the right during the 3
      business
      days following the notice of modification, whichever is longer, to reasonably
      object to the terms proposed Loan.  

    


    (c)  Pledge
      and Guaranty of the Company’s Chief Executive Officer.It
      shall
      be a condition precedent to any Loan that (i) Michael Shores pledge such number
      of shares of Common Stock beneficially owned by him equal to 150% of the initial
      amount of the Collateral pledged by the Investor at a price of $.50 per share,
      as further collateral for the Loan with such collateral being required to first
      be exhausted before a Lender looks to the Collateral for payment or
      satisfaction, and (ii) Michael Shores personally and unconditionally guarantee
      the Loan.

    


    ARTICLE
      2.

    REPRESENTATIONS
      AND WARRANTIES OF THE INVESTORS

    


    2.1
      Compliance
      with Law.
      The
      Investor’s trading activities with respect to shares of the Company’s Common
      Stock will be in compliance with all applicable state and federal securities
      laws, rules and regulations and rules and regulations of the principal market
      on
      which the Company’s Common Stock is listed.

    


    2.2
      Intent.
      The
      Investor is entering into this Agreement for his own account for investment
      purposes only and not with a view to or for sale in connection with any
      distribution of the Warrants. The Investor has no present arrangement (whether
      or not legally binding) at any time to sell the Warrants to or through any
      person or entity; provided, however, that by making the representations herein,
      the Investor does not agree to hold such securities for any minimum or other
      specific term and reserves the right to dispose of the shares underlying the
      Warrants at any time in accordance with federal and state securities laws
      applicable to such disposition.

    


    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    2.3 Investment
      Experience.
      The
      Investor acknowledges that he can bear the economic risk and complete loss
      of
      its investment in the securities and has such knowledge and experience in
      financial or business matters that it is capable of evaluating the merits and
      risks of the investment contemplated hereby.

    


    2.4.
       Authorization
      and Power.
      The
      Investor has the requisite power and authority to enter into and perform this
      Agreement and to purchase the Warrants being issued to him hereunder. This
      Agreement has been duly executed and delivered by the Investor and constitutes,
      or shall constitute when executed and delivered, a valid and binding obligation
      of the Investor enforceable against the Investor in accordance with the terms
      thereof,
      subject
      to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium
      and
      similar laws of general applicability relating to or affecting creditors’ rights
      generally and to general principles of equity.

    


    2.5. Information
      on Company.
      The
      Investor has been furnished with or has had access at the EDGAR Website of
      the
      Commission to the Company's Form 10-KSB for the year ended December 31, 2005
      as
      filed with the Commission, together with all subsequently filed Forms 10-QSB,
      8-K, and filings made with the Commission available at the EDGAR website
      (hereinafter referred to collectively as the "SEC
      Reports").
      In
      addition, the Investor has received in writing from the Company such other
      information concerning its operations, financial condition and other matters
      as
      the Investor has requested in writing (such other information is collectively,
      the "Other
      Written Information"),
      and
      considered all factors the Investor deems material in deciding on the
      advisability of investing in the securities. The
      Investor has had full opportunity to conduct, and has conducted, a complete
      and
      thorough due diligence investigation of the Company, and such opportunity has
      been made available to the Investor’s professional representative(s) to ask
      questions of and receive answers from representatives of the Company concerning
      the Company and its financial condition and prospects, as well as request
      additional information necessary to verify the accuracy of the SEC Reports
      and
      Other Written Information provided to Investor. The foregoing, however, does
      not
      limit or modify the representations and warranties of the Company contained
      in
      this Agreement or the right of Investor to rely thereon.

     

    2.6. Information
      on Investor.
      The
      Investor is, and will be at the time of the issuance of the Warrants, an
      "accredited investor", as such term is defined in Regulation D promulgated
      by
      the Commission under the 1933 Act, is experienced in investments and business
      matters, has made investments of a speculative nature and has purchased
      securities of United States publicly-owned companies in private placements
      in
      the past and, with its representatives, has such knowledge and experience in
      financial, tax and other business matters as to enable the Investor to utilize
      the information made available by the Company to evaluate the merits and risks
      of and to make an informed investment decision with respect to the proposed
      purchase, which represents a speculative investment. The Investor has the
      authority and is duly and legally qualified to purchase and own the Warrants.
      The Investor is able to bear the risk of such investment for an indefinite
      period and to afford a complete loss thereof. The information set forth on
      the
      signature page hereto regarding the Investor is accurate.  

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    2.7. Receipt
      of Warrants.
      The
      Investor will receive the Warrants as principal for his own account for
      investment only and not with a view toward, or for resale in connection with,
      the public sale or any distribution thereof.

     

    2.8. Compliance
      with Securities Act.
      The
      Investor understands and agrees that the Warrants have not been registered
      under
      the 1933 Act or any applicable state securities laws, by reason of their
      issuance in a transaction that does not require registration under the 1933
      Act
      (based in part on the accuracy of the representations and warranties of Investor
      contained herein), and that such Securities must be held indefinitely unless
      a
      subsequent disposition is registered under the 1933 Act or any applicable state
      securities laws or is exempt from
      such
      registration.
      Resales
      of the securities by the Investor will be made in compliance with all applicable
      securities laws.

     

    2.9. Communication
      of Offer.
      The
      offer to sell the securities was directly communicated to the Investor by the
      Company. At no time was the Investor presented with or solicited by any leaflet,
      newspaper or magazine article, radio or television advertisement, or any other
      form of general advertising or solicited or invited to attend a promotional
      meeting otherwise than in connection and concurrently with such communicated
      offer.

    


    2.10. Confidentiality/Public
      Announcement.
      From the
      date of this Agreement and until the Company makes a public announcement of
      the
      transactions contemplated by this Agreement by filing a Form 8-K, Investor
      agrees he will not disclose publicly or privately the nature of the transactions
      contemplated under this Agreement unless expressly agreed to in writing by
      the
      Company, or only to the extent required by law.

     

    2.11. No
      Governmental Review.
      The
      Investor understands that no United States federal or state agency or any other
      governmental or state agency has passed on or made recommendations or
      endorsement of the securities or the suitability of the investment in the
      securities nor have such authorities passed upon or endorsed the merits of
      the
      offering of the securities.

     

    2.12.
      No
      Market Manipulation.
      The
      Investor has not taken, and will not take, directly or indirectly, any action
      designed to, or that might reasonably be expected to, cause or result in
      stabilization or manipulation of the price of the Common Stock to facilitate
      the
      sale or resale of the securities or affect the price at which the securities
      may
      be issued or resold.

    


    2.13.
      Short
      Position and Short Sales.
      The
      Investor covenants that neither he nor any of his affiliates will engage in
      any
      illegal short sales of or illegal hedging transactions with respect to the
      Common Stock.

    


    2.14. Survival.
      The
      foregoing representations and warranties shall survive for a period of two
      years
      from the date hereof.

    


    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    ARTICLE
      3.

    REPRESENTATIONS
      AND WARRANTIES OF THE COMPANY

    


    3.1. Organization
      of the Company.
      The
      Company is a corporation duly incorporated and existing in good standing under
      the laws of the State of Nevada and has all requisite corporate authority to own
      its properties and to carry on its business as now being conducted.

    


    3.2. Authority.
      (i)
      The
      Company has the requisite corporate power and corporate authority to enter
      into
      and perform its obligations under this Agreement and to issue the Warrants
      and
      the Warrant Shares pursuant to their respective terms, (ii)
      the
      execution, issuance and delivery of the this Agreement, the Warrants by the
      Company and the consummation by it of the transactions contemplated thereby
      have
      been duly authorized by all necessary corporate action and no further consent
      or
      authorization of the Company or its Board of Directors or stockholders is
      required, and (iii)
      this
      Agreement and the Warrants have been duly executed and delivered by the Company
      and shall constitute valid and binding obligations of the Company enforceable
      against the Company in accordance with their terms, except as such
      enforceability may be limited by applicable bankruptcy, insolvency, or similar
      laws relating to, or affecting generally the enforcement of, creditors’ rights
      and remedies or by other equitable principles of general application. The
      Company has duly and validly authorized and reserved for issuance shares of
      Common Stock sufficient in number for the conversion of the exercise of the
      Warrants. The Company further acknowledges that its obligation to issue Warrant
      Shares upon exercise of the Warrants in accordance with this Agreement is
      absolute and unconditional regardless of the dilutive effect that such issuance
      may have on the ownership interests of other stockholders of the
      Company. 

    


    3.3. Common
      Stock.
      The
      Company has registered its Common Stock pursuant to Section 12(b)
      or
(g)
      of the
      Exchange Act and is in full compliance with all reporting requirements of the
      Exchange Act, and the Company is in compliance with all requirements for the
      continued listing or quotation of its Common Stock, and such Common Stock is
      currently listed or quoted on, the Principal Market. As of the date hereof,
      the
      Principal Market is the OTC Bulletin Board and the Company has not received
      any
      notice regarding, and to its knowledge there is no threat of, the termination
      or
      discontinuance of the eligibility of the Common Stock for such posting or
      listing.

    


    3.4. SEC
      Documents.
      The
      SEC
      Reports contain all material information relating to the Company and its
      operations and financial condition as of their respective dates which
      information is required to be disclosed therein
      and do
      not contain any untrue statement of a material fact or omit to state a material
      fact necessary in order to make the statements contained therein not misleading
      in light of the circumstances under which they were made.
      Since
      the date of the financial statements included in the SEC Reports, there has
      been
      no material adverse event relating to the Company's business, financial
      condition or affairs not disclosed in the SEC Reports. The SEC Reports do not
      contain any untrue statement of a material fact.

    


    3.5. Exemption
      from Registration; Valid Issuances.
      Subject
      to the accuracy of the Investor’s representations in Article 2, the sale of the
      Warrants and the Warrant Shares will not require registration under the
      Securities Act and/or any applicable state securities law (other than any SEC,
      Principal Market or state securities filings that may be required to be made
      by
      the Company subsequent to closing and any registration statement that may be
      filed pursuant hereto). When issued and paid for in accordance with the
      Warrants, the Warrant Shares will be duly and validly issued, fully paid, and
      non-assessable. Neither the sales of the Warrants or the Warrant Shares pursuant
      to, nor the Company’s performance of its obligations under this Agreement and
      the Warrants will (i)
      result
      in the creation or imposition by the Company of any liens, charges, claims
      or
      other encumbrances upon the Warrants or the Warrant Shares or, except as
      contemplated herein, any of the assets of the Company, or (ii)
      entitle
      the holders of outstanding capital shares to preemptive or other rights to
      subscribe for or acquire the capital shares or other securities of the Company.
      None of the securities shall subject the Investor to personal liability to
      the
      Company or its creditors by reason of the possession thereof.

    


    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    3.6. No
      Directed Selling, General Solicitation or Advertising in Regard to this
      Transaction.
      Neither
      the Company nor any of its affiliates nor, to the knowledge of the Company,
      any
      person acting on its or their behalf (i)
      has
      conducted or will conduct any general solicitation (as that term is used in
      Rule
502(c)
      of
      Regulation D)
      or
      general advertising with respect to the sale of the Warrants, or (ii)
      has made
      or will make any offers or sales of any security or solicited any offers to
      buy
      any security under any circumstances that would require registration of the
      sale
      of the securities under the Securities Act.

    


    3.7. No
      Conflicts.
      The
      execution, delivery and performance of this Agreement and the consummation
      by
      the Company of the transactions contemplated hereby or relating hereto do not
      and will not (i) result in a violation of the Company’s charter documents or
      bylaws or other organizational documents or (ii) conflict with, or constitute
      a
      default (or an event which with notice or lapse of time or both would become
      a
      default) under, or give to others any rights of termination, amendment,
      acceleration or cancellation of any agreement, indenture or instrument or
      obligation to which the Company is a party or by which its properties or assets
      are bound, or result in a violation of any law, rule, or regulation, or any
      order, judgment or decree of any court or governmental agency applicable to
      the
      Investor or its properties (except for such conflicts, defaults and violations
      as would not, individually or in the aggregate, have a material adverse effect
      on the Company). The Company is not required to obtain any consent,
      authorization or order of, or make any filing or registration with, any court
      or
      governmental agency in order for it to execute, deliver or perform any of its
      obligations under this Agreement sell the Warrants in accordance with the terms
      hereof, provided that for purposes of the representation made in this sentence,
      the Company is assuming and relying upon the accuracy of the relevant
      representations and agreements of the Investor herein.

    


    3.8. No
      Material Adverse Change.
      Since
      December 31, 2005 no material adverse effect has occurred or exists with respect
      to the Company, except as disclosed in the SEC Reports filed prior to the date
      hereof and available on EDGAR.

    


    3.9. Litigation
      and Other Proceedings.
      Except
      as disclosed in the SEC Reports, there are no lawsuits or proceedings pending
      or, to the knowledge of the Company, threatened, against the Company, nor has
      the Company received any written or oral notice of any such action, suit,
      proceeding or investigation, which could reasonably be expected to have a
      material adverse effect. Except as set forth in the SEC Reports, no judgment,
      order, writ, injunction or decree or award has been issued by or, to the
      knowledge of the Company, requested of any court, arbitrator or governmental
      agency which could result in a material adverse effect. There is no action,
      proceeding or investigation by the Company currently pending or that the Company
      intends to initiate.

    


    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    3.10. No
      Misleading or Untrue Communication.
      The
      Company and, to the knowledge of the Company, any person representing the
      Company, or any other person selling or offering to sell the Warrants in
      connection with the transaction contemplated by this Agreement, have not made,
      at any time, any oral communication in connection with the offer or sale of
      the
      same which, together with all such communications, including the SEC Reports,
      taken as a whole, contained any untrue statement of a material fact or omits
      to
      state a material fact necessary in order to make the statements contained herein
      or therein not misleading in light of the circumstances under which they were
      made.

    


    3.11 Reservation
      of Common Stock.
      As of
      the date hereof, the Company has reserved and the Company shall continue to
      reserve and keep available at all times shares of Common Stock for the purpose
      of enabling the Company to issue the Warrant Shares pursuant to any exercise
      of
      the Warrants in an amount not less than the number needed to provide for the
      issuance of Warrant Shares, as may be adjusted from time to time. The Company
      further agrees that if at any time the number of shares of Common Stock
issuable
      upon
      conversion of the Warrants would cause the Company to be obligated to issue
      a
      number of shares of Common Stock in excess of its authorized capital (after
      taking into account all other capital shares equivalents then existing), it
      shall promptly commence all necessary corporate and stockholder action necessary
      to increase its authorized capital so as to eliminate the aforesaid
      condition.

    


    3.12. Listing
      of Common Stock.
      The
      Company hereby agrees to maintain the listing or quotation of the Common Stock
      on a principal market, and as soon as required by the rules of the principal
      market to list the Warrant Shares on the principal market. The Company further
      agrees, if the Company applies to have the Common Stock traded on any other
      principal market, it will include in such application the Warrant Shares, and
      will take such other action as is necessary or desirable in the opinion of
      the
      Investor to cause the Warrant Shares to be listed on such other principal market
      as promptly as possible. The Company will take all action necessary to continue
      the listing and trading of its Common Stock on a principal market and will
      comply in all respects with the Company’s reporting, filing and other
      obligations under the bylaws or rules of the principal market. 

    


    3.12. Exchange
      Act Registration.
      The
      Company will cause its Common Stock to continue to be registered under Section
      12(b)
      or
(g)
      of the
      Exchange Act, will use its best efforts to comply in all respects with its
      reporting and filing obligations under the Exchange Act.

    


    3.13. Corporate
      Existence; Conflicting Agreements.
      The
      Company will take all steps necessary to preserve and continue the corporate
      existence of the Company. The Company shall not enter into any agreement, the
      terms of which agreement would restrict or impair the right or ability of the
      Company to perform any of its obligations under this Agreement or any of the
      other Transaction Documents.

    


    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    3.14.     
      Issuance
      of Warrant Shares.
      The
      sale of the Warrants and the issuance of the Warrant Shares pursuant to exercise
      of the Warrants shall be made in accordance with the provisions and requirements
      Section 4(2), 4(6)
      or
      Regulation D
      and any
      applicable state securities law. The Company shall make any necessary SEC and
      “blue sky” filings required to be made by the Company in connection with the
      sale of such securities to the Investor as required by all applicable
      laws.

    


    ARTICLE
      4.

    LEGENDS

    


    4.1          
      Legends.
      The
      Warrant Shares shall bear the following or similar legend: 

    


    "THE
      SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED OR APPLICABLE STATE SECURITIES LAWS. THESE
      SHARES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE
      OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH SECURITIES ACT OR ANY
      APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY
      TO TXP CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED."

     

    (i) Warrants
      Legend.
      The
      Warrants shall bear the following or
      similar legend:

     

    "THIS
      WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT
      BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR APPLICABLE
      STATE
      SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE
      OF
      THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN
      THE
      ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID
      ACT
      OR ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO TXP CORPORATION THAT SUCH REGISTRATION IS NOT
      REQUIRED."

    


    ARTICLE
      5.

    GENERAL
      PROVISIONS

     

    5.1  Specific
      Performance. The
      parties hereto acknowledge and agree that the breach of this Agreement would
      cause irreparable damage to the non-breaching parties and that the non-breaching
      parties will not have an adequate remedy at law. Therefore, the obligations
      of
      each of the parties under this Agreement, shall be enforceable by a decree
      of
      specific performance issued by any court of competent jurisdiction, and
      appropriate injunctive relief may be applied for and granted in connection
      therewith. Such remedies shall, however, be cumulative and not exclusive and
      shall be in addition to any other remedies which any party may have under this
      Agreement or otherwise.

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

    5.2  Further
      Assurances. The
      parties hereto each agree to execute and deliver such other documents or
      agreements and to take such other action as may be reasonably necessary or
      desirable for the implementation of this Agreement and the consummation of
      the
      transactions contemplated hereby.

     

    5.3  Governing
      Law; Venue.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of Texas. Venue.
      The
      parties (a) hereby irrevocably and unconditionally submit to the jurisdiction
      of
      the state and federal courts sitting in Dallas County, Texas for the purpose
      of
      any suit, action or other proceeding arising out of or based upon this
      Agreement, (b) agree not to commence any suit, action or other proceeding
      arising out of or based upon this Agreement except in the state and federal
      courts sitting in Dallas County, Texas, and (c) hereby waive, and agree not
      to
      assert, by way of motion, as a defense, or otherwise, in any such suit, action
      or proceeding, any claim that it is not subject personally to the jurisdiction
      of the above-referenced courts, that its property is exempt or immune from
      attachment or execution, that the suit, action or proceeding is brought in
      an
      inconvenient forum, that the venue of the suit, action or proceeding is improper
      or that this Agreement or the subject matter hereof may not be enforced in
      or by
      such court.

     

    5.4  Headings. Section
      headings of this Agreement are for reference purposes only and are to be given
      no effect in the construction or interpretation of this Agreement.

     

    5.5  Binding
      Effect. This
      Agreement is irrevocable and shall be binding upon and inure to the benefit
      of
      the parties and their respective successors and permitted assigns. 

     

    5.6  Counterparts.
      This
      Agreement may be executed in counterparts, each of which when executed by any
      party will be deemed to be an original and all of which counterparts will
      together constitute one and the same Agreement. Delivery of executed copies
      of
      this Agreement by telecopier will constitute proper delivery, provided that
      originally executed counterparts are delivered to the parties within a
      reasonable time thereafter.

     

    5.7  Expenses.
      Each
      party shall pay its own expenses incident to the negotiation, preparation and
      performance of this Agreement and the transactions contemplated hereby,
      including all fees and expenses of its counsel and accountants for all
      activities of such counsel and accountants undertaken pursuant to this
      Agreement, whether or not the transactions contemplated hereby are
      consummated.

     

    5.8  Amendments;
      Waivers.
      This
      Agreement may not be amended or modified, nor may compliance with any condition
      or covenant set forth herein be waived, except by a writing duly and validly
      executed by Investor and the Company, or, in the case of a waiver, the party
      waiving compliance. No delay on the part of any party in exercising any right,
      power or privilege hereunder shall operate as a waiver thereof, nor shall any
      waiver on the part of any party of any such right, power or privilege, or any
      single or partial exercise of any such right, power or privilege, preclude
      any
      further exercise thereof or the exercise of any other such right, power or
      privilege.

     

    5.10       
      Notices.
      All
      notices, requests, and other communications given or made pursuant to this
      Agreement shall be in writing and shall be deemed effectively given,
      delivered and received
      (i) upon
      personal delivery to the party to be notified; (ii) when sent by confirmed
      electronic mail or facsimile if sent during normal business hours of the
      recipient, and if not so confirmed, then on the next business day; (iii) five
      (5) days after having been sent by registered or certified mail, return receipt
      requested, postage prepaid; or (iv) one (1) business
      day
      after the
      business
      day of
      deposit
      with a nationally recognized overnight courier, specifying next-day delivery,
      with written verification of receipt. All communications shall be sent to the
      respective parties at their addresses as set forth on the
      signature page hereto
      or
      to
      such
      email address, facsimile number, or address as subsequently modified by written
      notice given in accordance with this Section 5.10. 

     

    [Remainder
      of page intentionally left blank.]

     

     

    
 

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    IN
      WITNESS WHEREOF, this Agreement has been duly executed as of the day and year
      first written above.

     

    
      	 	 	 
	 	TXP
              CORPORATION
	 
 	 
 	 
 
	 	By:  	/s/ Michael
              Shores
	 	
              
Name:
              Michael Shores
	 	Title:
              Chief Executive Officere 


    

     

    
      	 	 	 
	 	 	/s/ James
              Von
              Ehr, II 
	 	
              
James
              Von Ehr, II 


    

     

    


    
      
         

      

      
        12